Dr Kelly Winston Fife, MD | |
110 3rd St, Suite 180, Imperial Building, Henderson, KY 42420-2993 | |
(270) 827-3573 | |
(270) 827-1250 |
Full Name | Dr Kelly Winston Fife |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 110 3rd St, Henderson, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104990027 | NPI | - | NPPES |
64226053 | Medicaid | KY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 22605 (Kentucky) | Primary |
208000000X | Pediatrics | 01040820A (Indiana) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Kelly Winston Fife, MD 2000 N Elm St Ste 1b, Henderson, KY 42420-2385 Ph: (270) 844-8144 | Dr Kelly Winston Fife, MD 110 3rd St, Suite 180, Imperial Building, Henderson, KY 42420-2993 Ph: (270) 827-3573 |
News Archive
The genome of a newly-emerging superbug, commonly known as Steno, has just been sequenced. The results reveal an organism with a remarkable capacity for drug resistance. The research was carried out by scientists at the Wellcome Trust Sanger Institute near Cambridge and the University of Bristol.
Growing pains can mean one thing for a typical adolescent and quite another to an older teen with cerebral palsy attempting independence in an adult world. A unique program, the Indiana University School of Medicine Center for Youth and Adults with Conditions of Childhood (CYACC) is helping these youths spread their wings and live more independently.
Some vegetable cooking methods may be better than others when it comes to maintaining beneficial antioxidant levels, according to a new study in the Journal of Food Science, published by the Institute of Food Technologists.
Two well-known superbugs are the gram-positive methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). A new drug Teixobactin has shown promise against these microbes. The study titled, "The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study," was published in the latest issue of the journal Therapeutics and Prevention.
The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the treatment of cancer.
› Verified 8 days ago
Eric Douglas Ervin, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 110 3rd St, Suite 180, Henderson, KY 42420 Phone: 270-827-3573 Fax: 270-827-1250 | |
Dr. Fred L. Barnett, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1997 Barrett Ct, Henderson, KY 42420 Phone: 270-826-3538 Fax: 270-827-2779 | |
Mr. Garrett Chase Koon, D.O. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 2000 N Elm St, Henderson, KY 42420 Phone: 270-827-3573 Fax: 270-827-1250 | |
Maria C Aljabi, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 340 Starlite Dr, Henderson, KY 42420 Phone: 270-844-8027 Fax: 270-844-8183 | |
Dr. Lesa Sue Sutton-davis, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2000 N Elm St Ste 1b, Henderson, KY 42420 Phone: 270-844-8144 Fax: 270-844-8145 | |
Dr. Iyad A Aljabi, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 505 Klutey Park Plaza Dr, Henderson, KY 42420 Phone: 270-830-0313 Fax: 270-830-7117 |